Patritumab Deruxtecan (U3-1402) in Unresectable Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT04965766 · RECRUITING
Trial details
- NCT number
- NCT04965766
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-11
- Primary completion
- 2027-04-11
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.